Paradigm shift in the pharmacological treatment of type 2 diabetes mellitus
The options for pharmacological management of type 2 diabetes mellitus have exploded over the last decade or so. Availability of a variety of new drugs, oral as well as injectable, has made the choice of treatment more complex and challenging. Over a decade or so ago, glycemic (glucometabolic) contr...
Main Author: | Tejal Lathia |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
Series: | Journal of Mahatma Gandhi Institute of Medical Sciences |
Subjects: | |
Online Access: | http://www.jmgims.co.in/article.asp?issn=0971-9903;year=2020;volume=25;issue=1;spage=11;epage=14;aulast= |
Similar Items
-
The role of novel antihyperglycaemic agents in the treatment of Type 2 diabetes: From glycaemic control to cardiovascular protection
by: Žunić Tatjana, et al.
Published: (2020-01-01) -
Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus
by: Arash A. Nargesi, et al.
Published: (2021-07-01) -
SGLT2 Inhibitors: The Star in the Treatment of Type 2 Diabetes?
by: Yoshifumi Saisho
Published: (2020-05-01) -
Sodium-glucose cotransporter 2 inhibitor versus metformin as first-line therapy in patients with type 2 diabetes mellitus: a multi-institution database study
by: Tien-Hsing Chen, et al.
Published: (2020-11-01) -
Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes
by: Mohamed Abu-Farha, et al.
Published: (2022-09-01)